Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications

NCT05736874 is registered in ClinicalTrials.gov with Susanna Naggie, MD as lead sponsor.

NCT NCT05736874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05736874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
Lead sponsor
Susanna Naggie, MD
Phase
Phase 3
Overall status
Completed
Start date
August 6, 2021
Completion date
May 18, 2022
Enrollment
1,407 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

covid19